Volume 1922, Issue 1

Search all Reactions Weekly articles

September 2022

September 3, 2022

Filter by

Volume:

Sort by

Date published:

New to old Old to new

578 articles in this issue

Amphotericin-B/antihypertensives

Case report 03 September 2022 Pages: 51 - 51
Anaesthetics

Case report 03 September 2022 Pages: 52 - 52
Anakinra/tocilizumab

Case report 03 September 2022 Pages: 53 - 53
Analgesics

Case report 03 September 2022 Pages: 54 - 54
Anamorelin

Case report 03 September 2022 Pages: 55 - 55
Anthracyclines/trastuzumab

Case report 03 September 2022 Pages: 56 - 56
Antibacterials

Case report 03 September 2022 Pages: 57 - 57
Antibacterials

Case report 03 September 2022 Pages: 58 - 58
Antibacterials

Case report 03 September 2022 Pages: 59 - 59
Antibacterials/antiretrovirals

Case report 03 September 2022 Pages: 60 - 60
Anticoagulants/plasma/prothrombin-complex-concentrate

Case report 03 September 2022 Pages: 61 - 61
Antidepressants

Case report 03 September 2022 Pages: 62 - 62
Antidepressants/antipsychotics

Case report 03 September 2022 Pages: 63 - 63
Antiepileptic drugs/steroids

Case report 03 September 2022 Pages: 64 - 64
Antiepileptic-drugs

Case report 03 September 2022 Pages: 65 - 65
Antihyperglycaemics/antihypertensives

Case report 03 September 2022 Pages: 66 - 66
Antimicrobial drugs

Case report 03 September 2022 Pages: 67 - 67
Antineoplastics

Case report 03 September 2022 Pages: 68 - 68
Antineoplastics

Case report 03 September 2022 Pages: 69 - 69
Antineoplastics

Case report 03 September 2022 Pages: 70 - 70
Antineoplastics

Case report 03 September 2022 Pages: 71 - 71
Antineoplastics

Case report 03 September 2022 Pages: 72 - 72
Antineoplastics

Case report 03 September 2022 Pages: 73 - 73
Antineoplastics

Case report 03 September 2022 Pages: 74 - 74
Antineoplastics

Case report 03 September 2022 Pages: 75 - 75
Antineoplastics

Case report 03 September 2022 Pages: 76 - 76
Antineoplastics

Case report 03 September 2022 Pages: 77 - 77
Antineoplastics

Case report 03 September 2022 Pages: 78 - 78
Antineoplastics

Case report 03 September 2022 Pages: 79 - 79
Antineoplastics

Case report 03 September 2022 Pages: 80 - 80
Antineoplastics

Case report 03 September 2022 Pages: 81 - 81
Antineoplastics

Case report 03 September 2022 Pages: 82 - 82
Antineoplastics

Case report 03 September 2022 Pages: 83 - 83
Antineoplastics

Case report 03 September 2022 Pages: 84 - 84
Antineoplastics

Case report 03 September 2022 Pages: 85 - 85
Antineoplastics/antivirals

Case report 03 September 2022 Pages: 86 - 86
Antineoplastics/atorvastatin

Case report 03 September 2022 Pages: 87 - 87
Antineoplastics/nivolumab/osimertinib

Case report 03 September 2022 Pages: 88 - 88
Antiretrovirals

Case report 03 September 2022 Pages: 89 - 89
Antiretrovirals/Glucocorticoids

Case report 03 September 2022 Pages: 90 - 90
Antithymocyte-globulin/ciclosporin/eltrombopag

Case report 03 September 2022 Pages: 91 - 91
Antithymocyte-globulin/ciclosporin/mycophenolate-mofetil

Case report 03 September 2022 Pages: 92 - 92
Antituberculars

Case report 03 September 2022 Pages: 93 - 93
Apixaban

Case report 03 September 2022 Pages: 94 - 94
Apixaban/tozinameran

Case report 03 September 2022 Pages: 95 - 95
Apremilast/secukinumab

Case report 03 September 2022 Pages: 96 - 96
Aspirin

Case report 03 September 2022 Pages: 97 - 97
Aspirin/clopidogrel

Case report 03 September 2022 Pages: 98 - 98
Aspirin/clopidogrel

Case report 03 September 2022 Pages: 99 - 99
Aspirin/clopidogrel

Case report 03 September 2022 Pages: 100 - 100

Volume 1922, Issue 1

Search

Navigation